Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.44
+0.29 (2.21%)
At close: Mar 6, 2026, 4:00 PM EST
13.40
-0.04 (-0.30%)
After-hours: Mar 6, 2026, 7:59 PM EST
Intellia Therapeutics Employees
Intellia Therapeutics had 377 employees as of December 31, 2025. The number of employees decreased by 26 or -6.45% compared to the previous year.
Employees
377
Change (1Y)
-26
Growth (1Y)
-6.45%
Revenue / Employee
$179,499
Profits / Employee
-$1,094,679
Market Cap
1.59B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 952 |
| Agios Pharmaceuticals | 540 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 291 |
| Innoviva | 159 |
| Kodiak Sciences | 123 |
| AnaptysBio | 104 |
| Nanobiotix | 103 |
NTLA News
- 1 day ago - Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026 - GlobeNewsWire
- 5 days ago - Intellia Therapeutics Stock Gains — FDA Lifts Clinical Hold On Pivotal Trial - Benzinga
- 5 days ago - US FDA lifts clinical hold on Intellia's heart disease gene therapy trial - Reuters
- 5 days ago - Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM - GlobeNewsWire
- 9 days ago - Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates - GlobeNewsWire
- 11 days ago - Intellia Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire